BioWorld Science

Dec. 27, 2000

View Archived Issues

Potent and selective octapeptide sst3 receptor antagonist identified by Swiss, U.S. researchers

Read More

Myogen and BASF to codevelop BSF-208075

Read More

Zonagen and Wyeth-Ayerst sign human contraceptive vaccine agreement

Read More

Oxford GlycoSciences and Pfizer enter biomarker discovery alliance

Read More

AstraZeneca continues to make progress across development portfolio

Read More

SLIL designs conformationally restricted polyamine analogues for cancer therapy

Read More

AstraZeneca seeks FDA approval for pediatric indication of Naropin

Read More

EU recommends approval of PegIntron/Rebetol combination for hepatitis C treatment

Read More

CeNeS grants license to Shire for dopamine D1 agonist program

Read More

Japanese launch of maxacalcitol announced

Read More

Inflazyme's novel asthma therapy enters phase II following U.K. approval

Read More

R.W. Johnson delays North American phase III trial of influenza inhibitor

Read More

Starlix approved by FDA for treatment of type 2 diabetes

Read More

Actis for erectile dysfunction approved by FDA for OTC marketing

Read More

Once-daily Detrol approved by FDA for treatment of overactive bladder

Read More

Novel method for treating autoimmune diseases revealed by UAB Research Foundation

Read More

Sumitomo discloses thiourea derivatives with ECE-inhibitory activity

Read More

Sumitomo reports quinazoline derivatives with potential for allergic disease treatment

Read More

Novel steroid compounds demonstrate anticancer potential

Read More

Tanabe Seiyaku claims isoquinoline derivatives with cardiovascular activity

Read More